Ultrazonix DNT AB/ Bone Support AB
IFEX Group Investment Banking has signed a letter of intent with an option to acquire a significant stake in two Swedish medical technology companies: Ultrazonix DNT AB and Bone Support AB. Ultrazonix is a Malmö-based medical-technology that provides help for patients with spinal problems through the use of a new technique based upon high intensity focused ultrasound thereby avoiding major surgery. Bone Support is a Scandinavian biotech company focusing on the development of injectable bone materials, based on synthetically produced ceramics. Ultrazonix is a portfolio company of Scandinavian Life Science Ventures, the latter providing Skr20mk for a 40% stake in the company in late 2001. Bone Support has been funded by Teknoinvest and InnovationsKapital
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Czech Republic-headquartered family office is targeting DACH and CEE region deals
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds
Back to Top








